|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/10 | (2006.01) |
| A61K 31/275 | (2013.01) | ||
| A61K 31/275 | (2006.01) | ||
| A61P 9/04 | (2018.01) | ||
| A61P 9/04 | (2006.01) | ||
| A61K 9/0019 | (2013.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61K 9/4866 | (2013.01) | ||
| A61K 9/48 | (2006.01) |
| (11) | Patento numeris | 3565540 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18736230.6 |
| Europos patento paraiškos padavimo data | 2018-01-05 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-11-13 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-12-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2018/012625 |
| Data | 2018-01-05 |
| (87) | Numeris | WO 2018/129347 |
| Data | 2018-07-12 |
| (30) | Numeris | Data | Šalis |
| 201762443387 P | 2017-01-06 | US | |
| 201762506843 P | 2017-05-16 | US |
| (72) |
MARCHETTI, Carlo , US
DINARELLO, Charles A. , US
|
| (73) |
Olatec Therapeutics LLC ,
800 Fifth Avenue, 25th Floor, New York, NY 10065,
US
|
| (54) | A PHARMACEUTICAL COMPOSITION FOR USE IN TREATING CARDIOVASCULAR DISEASES |
| A PHARMACEUTICAL COMPOSITION FOR USE IN TREATING CARDIOVASCULAR DISEASES |